HLB Innovation Co., Ltd. (024850) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for HLB Innovation Co., Ltd. (024850:KRX), powered by AI.

Current Price
₩23,100
P/E Ratio
-160.9
Market Cap
733.0B
Sector
Technology
What is the HLB Innovation Co., Ltd. stock price forecast?

HLB Innovation Co., Ltd. is currently trading at ₩23,100. View real-time AI analysis on Alpha Lenz.

What is HLB Innovation Co., Ltd. insider trading activity?

View the latest insider trading data for HLB Innovation Co., Ltd. on Alpha Lenz.

What is HLB Innovation Co., Ltd.'s P/E ratio?

HLB Innovation Co., Ltd.'s P/E ratio is -160.9.

HLB Innovation Co., Ltd.

KRX · 024850
₩23,100
Ask about HLB Innovation Co., Ltd.'s future dividend policy...
Alpha Chat Insight

HLB Innovation Co., Ltd. trades at a P/E of -160.9 (undervalued) with modest ROE of -8.1%.

Ask for details

Company Overview

HLB Innovation Co., Ltd. is a company primarily engaged in pharmaceutical research and biotechnology development. This company focuses on innovative healthcare solutions, aiming to address global health challenges through advanced biotechnological applications. HLB Innovation is known for its strong commitment to R&D, concentrating on the development of novel drugs and therapeutic solutions. It operates in various sectors of the biotechnology industry, particularly in areas related to cancer treatment and regenerative medicine. With a robust portfolio of patents and proprietary technologies, the company positions itself as a key player in the biopharmaceutical landscape. HLB Innovation works with both domestic and international markets, collaborating with research institutions and other pharmaceutical companies to enhance its global impact. Its strategic involvement in cutting-edge scientific advancements contributes significantly to the evolving needs of the medical field. This company's activities are crucial in the pharmaceutical market as it drives innovation and supports the development of next-generation medical treatments.

CEO김홍철, BRYANBYONGJIN.KIM(각자 대표)
SectorTechnology
IndustrySemiconductor Equipment & Materials
0

Company Statistics

FY 2024

Profile

₩733,034,563,800Market Cap
₩25,355,832,330Revenue
31.73MShares Out
0Employees

Margins

11.22%Gross
-34.33%EBITDA
-46.86%Operating
-48.56%Pre-Tax
-48.78%Net

Valuation

-160.92P/E
8.08P/B
78.20EV/Sales
-225.56EV/EBITDA
-71.79P/FCF

Growth (CAGR)

-12.86%Rev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-6.87%ROA
-8.13%ROE
-6.10%ROIC

Financial Health

₩31,743,566,200Cash & Cash Equivalents
₩-15,715,411,060Net Debt
6.36%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

HLB Innovation Co., Ltd. (ticker: 024850) is a company listed on KRX in the Technology sector (Semiconductor Equipment & Materials). Market cap is $733.0B.

The current price is ₩23,100 with a P/E ratio of -160.92x and P/B of 8.08x.

ROE is -8.13% and operating margin is -46.86%. Annual revenue is $25.4B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
HLB Innovation Co., Ltd. (Technology) Stock Forecast & Analysis ₩23,100 | Alpha Lenz